Your browser doesn't support javascript.
loading
An agonistic anti-Tie2 antibody suppresses the normal-to-tumor vascular transition in the glioblastoma invasion zone.
Lee, Eunhyeong; Lee, Eun-Ah; Kong, Eunji; Chon, Haemin; Llaiqui-Condori, Melissa; Park, Cheon Ho; Park, Beom Yong; Kang, Nu Ri; Yoo, Jin-San; Lee, Hyun-Soo; Kim, Hyung-Seok; Park, Sung-Hong; Choi, Seung-Won; Vestweber, Dietmar; Lee, Jeong Ho; Kim, Pilhan; Lee, Weon Sup; Kim, Injune.
Afiliação
  • Lee E; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
  • Lee EA; R&D Center, PharmAbcine Inc., Daejeon, 34047, Republic of Korea.
  • Kong E; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
  • Chon H; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
  • Llaiqui-Condori M; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
  • Park CH; R&D Center, PharmAbcine Inc., Daejeon, 34047, Republic of Korea.
  • Park BY; R&D Center, PharmAbcine Inc., Daejeon, 34047, Republic of Korea.
  • Kang NR; R&D Center, PharmAbcine Inc., Daejeon, 34047, Republic of Korea.
  • Yoo JS; R&D Center, PharmAbcine Inc., Daejeon, 34047, Republic of Korea.
  • Lee HS; Department of Bio and Brain Engineering, KAIST, Daejeon, 34141, Republic of Korea.
  • Kim HS; Department of Forensic Medicine, Chonnam National University Medical School, Gwangju, 61463, Republic of Korea.
  • Park SH; Department of Bio and Brain Engineering, KAIST, Daejeon, 34141, Republic of Korea.
  • Choi SW; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, Seoul, 06351, Republic of Korea.
  • Vestweber D; Max Planck Institute for Molecular Biomedicine, D-48149, Muenster, Germany.
  • Lee JH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
  • Kim P; BioMedical Research Center, KAIST, Daejeon, 34141, Republic of Korea.
  • Lee WS; SoVarGen, Inc., Daejeon, 34051, Republic of Korea.
  • Kim I; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
Exp Mol Med ; 55(2): 470-484, 2023 02.
Article em En | MEDLINE | ID: mdl-36828931
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Exp Mol Med Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Exp Mol Med Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article